Early manifestation of nephropathy in rats with arterial calcinosis

Renal Failure

Volumn 25, Issue 3, 2003, Pages 355-366

  Quaglia, Nora B ^b   Brandoni, Anabel ^a,c   Ferri, Alejandro ^a   Torres, Adriana M ^a,c  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Arterial calcinosis; OAT1; Organic anions; Renal function

Indexed keywords

CALCIUM; COLECALCIFEROL; ORGANIC ANION TRANSPORTER; SULFANILAMIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CALCIFICATION; ARTICLE; BASOLATERAL MEMBRANE; CALCINOSIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOBLOTTING; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY CORTEX; KIDNEY FUNCTION; MALE; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA, ABDOMINAL; AORTIC DISEASES; BLOOD PRESSURE; CALCINOSIS; CALCIUM; CHOLECALCIFEROL; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; ORGANIC ANION TRANSPORT PROTEIN 1; RANDOMIZED CONTROLLED TRIALS; RATS; RATS, WISTAR; RENAL CIRCULATION; SULFANILAMIDES; SYSTOLE; TIME FACTORS;

EID: 0038654472     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120021150     Document Type: Article

References (28)

1. Fleckenstein, A.; Frey, M.; Zorn, J.; Fleckenstein-Grun, G. The role of calcium in the pathogenesis of experimental arteriosclerosis. Trends Pharmacol. Sci. 1987, 8, 496-501.
2. Fleckenstein, A.; Frey, M.; Fleckenstein-Grun, G. Antihypertensive and arterial anticalcinotic effects of calcium antagonists. Am. J. Cardiol. 1986, 57, 1D-10D.
3. Henrion, D.; Chillon, J.M.; Godeau, G.; Muller, F.; Capdeville-Atkinson, C.; Hoffman, M.; Atkinson, J. The consequences of aortic calcium overload following vitamin D3 plus nicotine treatment in young rats. J. Hypertens. 1991, 9, 919-921.
4. Fleckestein-Grun, G.; Thimm, F.; Frey, M.; Czirfusz, A. Role of calcium in arteriosclerosis-Experimental evaluation of antiarteriosclerotic potencies of Ca antagonists. Basic. Res. Cardiol. 1994, 89, 145-159.
5. Rucker, R.B.; Ford, D.; Riemann, W.G.; Tom, K. Additional evidence for the binding of calcium ions to elastin at neutral sites. Calcif. Tissue Res. 1974, 14, 317-325.
6. Atkinson, J. Vascular calcium overload - physiological and pharmacological consequences. Drugs 1992, 44, 111-118.
7. Brenner, B.B.; Rector, F.C. The Kidney; 5th Ed.; W.B. Saunders Company: Pennsylvania, USA, 1996; 607-625.
8. Van Aubel, R.; Masereeuw, R.; Russel, F.G.M. Molecular pharmacology of organic anion transporters. Am. J. Physiol. 2000, 279, F216-F232.
9. Inui, K.-I.; Masuda, S.; Saito, H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 2000, 58, 944-958.
10. Berkhin, E.B.; Humphreys, M.H. Regulation of renal tubular secretion of organic compounds. Kidney Int. 2001, 59, 17-30.
11. Quaglia, N.B.; Hofer, C.G.; Torres, A.M. Pharmacokinetics of organic anions in rats with arterial calcinosis. Clin. Exp. Pharmacol. Physiol. 2002, 29, 48-52.
12. Garcia, V.M.C.; Girardi, G.; Ochoa, J.E.; Torres, A.M.; Elias, M.M. Early manifestations of nephropathy in alloxan-treated rats. Renal Fail. 1998, 20, 551-564.
13. Torres, A.M.; Rodríguez, J.V.; Elías, M. Vulnerability of the thick ascending limb to glutathione depletion in rat kidney: effects of diuretics and indomethacine. J. Pharmacol. Exp. Ther. 1989, 250, 247-253.
14. Cerrutti, J.A.; Quaglia, N.B.; Torres, A.M. Characterization of the mechanisms involved in the gender differences in p-aminohippurate renal elimination in rats. Can. J. Physiol. Pharmacol. 2001, 79, 805-813.
15. Roe, H.H. A photometric method for determination of inulin in plasma and urine. J. Biol. Chem. 1949, 178, 839-844.
16. Bratton, A.C.; Marshall E.K., Jr. Determination of p-aminohippurate. J. Biol. Chem. 1939, 128, 537-542.
17. Glenny, R.W. Manual for Using Fluorescent Microspheres to Measure Regional Organ Perfusion; Fluorescent microsphere Resource Center, University of Washington, 1996.
18. Jensen, R.E.; Berndt, W.O. Epinephrine and norephinephrine enhance p-aminohippurate transport into basolateral membrane vesicles. J. Pharmacol. Exp. Ther. 1988, 244, 543-549.
19. Cerrutti, J.A.; Brandoni, A.; Quaglia, N.B.; Torres, A.M. Sex differences in p-aminohippuric acid transport in rat kidney: role of membrane fluidity and expression of OAT1. Mol. Cell. Biochem. 2002, 233, 175-179.
20. Shah, V.; Cao, S.; Hendrickson, H.; Yao, J.; Katusic, Z.S. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am. J. Physiol. 2001, 280, G1209-G1216.
21. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J. Hepatology 1997, 27, 1051-1056.
22. Bukoski, R.D.; Wang, D.; Wagman, D.W. Injection of 1,25 (OH)2 vitamin D enhances resistance artery contractile properties. Hypertension 1990, 16, 523-531.
23. Seldin, D.W. Renal handling of calcium. Nephron 1999, 81, 2-7.
24. Brickman, A.S.; Coburn, J.W.; Norman, A.W.; Massry, S.G. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure. Am. J. Med. 1974, 57, 28-30.
25. Humes, H.D.; Ichikawa, I.; Troy, J.L.; Brenner, B.M. Evidence for a parathyroid hormone-dependent influence of calcium in the glomerular filtration. J. Clin. Invest. 1978, 61, 32-35.
26. Fleck, Ch.; Braunlich, H. Interrelationships between excretion of drugs via urine and bile. Progress in Pharmacology and Clinical Pharmacology 1991, 8, 511-529.
27. Jones, G.; Strugnell, S.A.; DeLuca, H. Current understanding and the molecular actions of vitamin D. Physiological Reviews 1998, 78, 1193-1222.
28. Brown, A.J.; Dusso, A.; Slatopolsky, E. Vitamin D. Am. J. Physiol. 1999, 277, F157-F175.